PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Royal Brompton and Harefield NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.\', \'National Institute for Health Research Biomedical Research Centre, University of Nottingham, Nottingham, UK. Electronic address: gisli.jenkins@nottingham.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2600(20)30225-310.1016/S2213-2600(20)30225-3
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 32422178
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32422178>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32422178>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all